WNT5A and melanoma: Recent studies have suggested that Wnt5a signaling may regulate the peripheral inflammatory response in chronic disorders, including sepsis [70], rheumatoid arthritis [71], atherosclerosis [72], melanoma [73], and psoriasis [74].